Genetic Variants in the SCN9A Gene are Detected in a Minority of Erythromelalgia Patients

Gain-of-function variants in the voltage-gated sodium channel Nav1.7, encoded by the SCN9A gene, have previously been identified in patients with erythromelalgia, a clinical diagnosis defined by intermittent attacks of painful, hot, swollen, and red skin, predominantly involving the hands and feet....

Full description

Saved in:
Bibliographic Details
Main Authors: Mari Skystad Kvernebo, Celene Grayson, Ioannis M. Stylianou, Virginia Woloshen, Christopher Radomski, Cato Mørk, Knut Kvernebo
Format: Article
Language:English
Published: Medical Journals Sweden 2025-01-01
Series:Acta Dermato-Venereologica
Subjects:
Online Access:https://medicaljournalssweden.se/actadv/article/view/42022
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589705924837376
author Mari Skystad Kvernebo
Celene Grayson
Ioannis M. Stylianou
Virginia Woloshen
Christopher Radomski
Cato Mørk
Knut Kvernebo
author_facet Mari Skystad Kvernebo
Celene Grayson
Ioannis M. Stylianou
Virginia Woloshen
Christopher Radomski
Cato Mørk
Knut Kvernebo
author_sort Mari Skystad Kvernebo
collection DOAJ
description Gain-of-function variants in the voltage-gated sodium channel Nav1.7, encoded by the SCN9A gene, have previously been identified in patients with erythromelalgia, a clinical diagnosis defined by intermittent attacks of painful, hot, swollen, and red skin, predominantly involving the hands and feet. Symptoms are induced or aggravated by warming and relieved by cooling. In primary erythromelalgia there is no known underlying disease. This study investigated the frequency of SCN9A variants in a cohort of primary erythromelalgia patients collected at a single centre, and examined the clinical signs and symptoms associated with identified variants. One hundred patients with possible erythromelalgia were collected prospectively and evaluated by clinical examination. Thirty-five patients fulfilling the clinical criteria of primary erythromelalgia were screened for variants in SCN9A. Five were found to carry likely causal variants, including a variant found in 2 related individuals and a variant not previously described in patients with erythromelalgia. The clinical findings differed significantly between the patients. Overall, in this cohort only 4/34 (11.7%) of unrelated patients had erythromelalgia likely caused by gain-of-function variants in SCN9A. Variants in SCN9A are therefore likely to cause or contribute to primary erythromelalgia in only a small proportion of patients.
format Article
id doaj-art-73d6034b209b499c936039f9fd0a2e01
institution Kabale University
issn 0001-5555
1651-2057
language English
publishDate 2025-01-01
publisher Medical Journals Sweden
record_format Article
series Acta Dermato-Venereologica
spelling doaj-art-73d6034b209b499c936039f9fd0a2e012025-01-24T09:08:00ZengMedical Journals SwedenActa Dermato-Venereologica0001-55551651-20572025-01-0110510.2340/actadv.v105.42022Genetic Variants in the SCN9A Gene are Detected in a Minority of Erythromelalgia PatientsMari Skystad Kvernebo0Celene Grayson1Ioannis M. Stylianou2Virginia Woloshen3Christopher Radomski4Cato Mørk5Knut Kvernebo6Department of Dermatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Aleris Medical Center, Stømmen, NorwayXenon Pharmaceuticals Inc., Burnaby, CanadaXenon Pharmaceuticals Inc., Burnaby, CanadaXenon Pharmaceuticals Inc., Burnaby, CanadaXenon Pharmaceuticals Inc., Burnaby, CanadaAkershus Dermatology Centre, Lørenskog, NorwayInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwayGain-of-function variants in the voltage-gated sodium channel Nav1.7, encoded by the SCN9A gene, have previously been identified in patients with erythromelalgia, a clinical diagnosis defined by intermittent attacks of painful, hot, swollen, and red skin, predominantly involving the hands and feet. Symptoms are induced or aggravated by warming and relieved by cooling. In primary erythromelalgia there is no known underlying disease. This study investigated the frequency of SCN9A variants in a cohort of primary erythromelalgia patients collected at a single centre, and examined the clinical signs and symptoms associated with identified variants. One hundred patients with possible erythromelalgia were collected prospectively and evaluated by clinical examination. Thirty-five patients fulfilling the clinical criteria of primary erythromelalgia were screened for variants in SCN9A. Five were found to carry likely causal variants, including a variant found in 2 related individuals and a variant not previously described in patients with erythromelalgia. The clinical findings differed significantly between the patients. Overall, in this cohort only 4/34 (11.7%) of unrelated patients had erythromelalgia likely caused by gain-of-function variants in SCN9A. Variants in SCN9A are therefore likely to cause or contribute to primary erythromelalgia in only a small proportion of patients. https://medicaljournalssweden.se/actadv/article/view/42022ErythromelalgiaNAV1.7 voltage gated sodium channelGeneticsetiology
spellingShingle Mari Skystad Kvernebo
Celene Grayson
Ioannis M. Stylianou
Virginia Woloshen
Christopher Radomski
Cato Mørk
Knut Kvernebo
Genetic Variants in the SCN9A Gene are Detected in a Minority of Erythromelalgia Patients
Acta Dermato-Venereologica
Erythromelalgia
NAV1.7 voltage gated sodium channel
Genetics
etiology
title Genetic Variants in the SCN9A Gene are Detected in a Minority of Erythromelalgia Patients
title_full Genetic Variants in the SCN9A Gene are Detected in a Minority of Erythromelalgia Patients
title_fullStr Genetic Variants in the SCN9A Gene are Detected in a Minority of Erythromelalgia Patients
title_full_unstemmed Genetic Variants in the SCN9A Gene are Detected in a Minority of Erythromelalgia Patients
title_short Genetic Variants in the SCN9A Gene are Detected in a Minority of Erythromelalgia Patients
title_sort genetic variants in the scn9a gene are detected in a minority of erythromelalgia patients
topic Erythromelalgia
NAV1.7 voltage gated sodium channel
Genetics
etiology
url https://medicaljournalssweden.se/actadv/article/view/42022
work_keys_str_mv AT mariskystadkvernebo geneticvariantsinthescn9agenearedetectedinaminorityoferythromelalgiapatients
AT celenegrayson geneticvariantsinthescn9agenearedetectedinaminorityoferythromelalgiapatients
AT ioannismstylianou geneticvariantsinthescn9agenearedetectedinaminorityoferythromelalgiapatients
AT virginiawoloshen geneticvariantsinthescn9agenearedetectedinaminorityoferythromelalgiapatients
AT christopherradomski geneticvariantsinthescn9agenearedetectedinaminorityoferythromelalgiapatients
AT catomørk geneticvariantsinthescn9agenearedetectedinaminorityoferythromelalgiapatients
AT knutkvernebo geneticvariantsinthescn9agenearedetectedinaminorityoferythromelalgiapatients